Prospective Grant of Exclusive License: Veterinary Vaccine and Therapeutic Uses of Bartonella Henselae (Formerly Rochalimaea Henselae) Organisms

Résumé

This is notice in accordance with 15 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i) that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of a worldwide, limited field of use, exclusive license to practice the inventions embodied in the patents and patent applications referred to below to Paravax, Inc., having a place of business in Fort Collins, Colorado. The patent rights in these inventions have been assigned to the government of the United States of America. The patents and patent applications to be licensed are: ``Methods and Compositions for Diagnosing Cat Scratch Disease and Bacillary Angiomatosis Caused by Rochalimaea henselae,'' U.S. Patent Application Serial No. 07/822,539 filed 17 Jan 92 (U.S. Patent No. 5,399,485 issued 21 Mar 95) and related cases, which include all continuation applications, divisional applications, continuation-in-part applications, and foreign counterpart applications. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within sixty (60) days from the d